Erin Joseph

1.2k total citations
31 papers, 985 citations indexed

About

Erin Joseph is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Erin Joseph has authored 31 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Biomaterials. Recurrent topics in Erin Joseph's work include Cancer therapeutics and mechanisms (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Epigenetics and DNA Methylation (4 papers). Erin Joseph is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Epigenetics and DNA Methylation (4 papers). Erin Joseph collaborates with scholars based in United States, Netherlands and Canada. Erin Joseph's co-authors include Julie L. Eiseman, Merrill J. Egorin, Robert A. Parise, Joseph M. Covey, Deborah R. Hamburger, William C. Zamboni, Jan H. Beumer, Jing Lan, Jianxia Guo and Margaret Tonda and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Erin Joseph

31 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erin Joseph United States	17	584	242	228	169	66	31	985
Seong H. Jang United States	11	333 0.6×	344 1.4×	259 1.1×	258 1.5×	37 0.6×	20	957
Dawn Waterhouse Canada	20	704 1.2×	568 2.3×	308 1.4×	360 2.1×	72 1.1×	36	1.4k
Grzegorz Pietrzyński Poland	9	446 0.8×	415 1.7×	148 0.6×	190 1.1×	77 1.2×	15	910
Florence Gattacceca France	15	326 0.6×	235 1.0×	106 0.5×	172 1.0×	107 1.6×	33	809
Séverine Wack France	15	358 0.6×	206 0.9×	129 0.6×	196 1.2×	27 0.4×	16	673
Rubi Mahato United States	5	418 0.7×	214 0.9×	246 1.1×	195 1.2×	51 0.8×	5	795
Malathi Anantha Canada	19	550 0.9×	518 2.1×	194 0.9×	292 1.7×	62 0.9×	37	1.0k
Hilary Thomas United Kingdom	17	606 1.0×	144 0.6×	808 3.5×	220 1.3×	68 1.0×	26	1.4k
Hayley J. Paholak United States	12	422 0.7×	193 0.8×	442 1.9×	246 1.5×	169 2.6×	15	1.0k
Aquilur Rahman United States	22	608 1.0×	598 2.5×	557 2.4×	173 1.0×	68 1.0×	48	1.4k

Countries citing papers authored by Erin Joseph

Since Specialization

Citations

This map shows the geographic impact of Erin Joseph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Joseph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Joseph more than expected).

Fields of papers citing papers by Erin Joseph

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Joseph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Joseph. The network helps show where Erin Joseph may publish in the future.

Co-authorship network of co-authors of Erin Joseph

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Joseph. A scholar is included among the top collaborators of Erin Joseph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Joseph. Erin Joseph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eiseman, Julie L., Jing Lan, Jianxia Guo, Erin Joseph, & Ivana Vučenik. (2011). Pharmacokinetics and tissue distribution of inositol hexaphosphate in C.B17 SCID mice bearing human breast cancer xenografts. Metabolism. 60(10). 1465–1474. 19 indexed citations

Zamboni, William C., Julie L. Eiseman, Sandra Strychor, et al.. (2010). Tumor disposition of pegylated liposomal CKD-602 and the reticuloendothelial system in preclinical tumor models. Journal of Liposome Research. 21(1). 70–80. 23 indexed citations

Zamboni, William C., Laura Jung, Sandra Strychor, et al.. (2008). Plasma and tissue disposition of non-liposomal DB-67 and liposomal DB-67 in C.B-17 SCID mice. Investigational New Drugs. 26(5). 399–406. 6 indexed citations

Guo, Jianxia, Robert A. Parise, Erin Joseph, et al.. (2008). Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice. Cancer Chemotherapy and Pharmacology. 63(4). 615–625. 101 indexed citations

Kanick, Stephen C., Julie L. Eiseman, Erin Joseph, Jianxia Guo, & Robert S. Parker. (2007). Noninvasive and nondestructive optical spectroscopic measurement of motexafin gadolinium in mouse tissues: Comparison to high-performance liquid chromatography. Journal of Photochemistry and Photobiology B Biology. 88(2-3). 90–104. 9 indexed citations

Beumer, Jan H., Julie L. Eiseman, Robert A. Parise, et al.. (2007). Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice. Cancer Chemotherapy and Pharmacology. 62(3). 457–64. 21 indexed citations

Parise, Robert A., Merrill J. Egorin, Julie L. Eiseman, et al.. (2007). Quantitative determination of the cytidine deaminase inhibitor tetrahydrouridine (THU) in mouse plasma by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 21(13). 1991–1997. 11 indexed citations

Zamboni, William C., Sandra Strychor, Erin Joseph, et al.. (2007). Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts. Cancer Chemotherapy and Pharmacology. 62(3). 417–426. 22 indexed citations

Guo, Jianxia, Robert A. Parise, Erin Joseph, et al.. (2007). Pharmacology and antitumor activity of a quinolinedione Cdc25 phosphatase inhibitor DA3003-1 (NSC 663284).. Anticancer Research. 27(5A). 3067–73. 18 indexed citations

10.

Florian, Jeffry, William C. Zamboni, Julie L. Eiseman, et al.. (2006). A physiologically-based pharmacokinetic (PBPK) model of docetaxel in SCID mice bearing SKOV3 human ovarian cancer xenografts. Cancer Research. 66. 730–730. 1 indexed citations

11.

Strychor, Sandra, Julie L. Eiseman, Erin Joseph, et al.. (2006). Plasma, tissue and tumor disposition of STEALTH® liposomal CKD-602 (S-CKD602) and non-liposomal CKD-602, a camptothecin analogue, in mice bearing A375 human melanoma xenografts. Cancer Research. 66. 721–721. 3 indexed citations

12.

Beumer, Jan H., Erin Joseph, Merrill J. Egorin, Joseph M. Covey, & Julie L. Eiseman. (2005). Quantitative determination of zebularine (NSC 309132), a DNA methyltransferase inhibitor, and three metabolites in murine plasma by high-performance liquid chromatography coupled with on-line radioactivity detection. Journal of Chromatography B. 831(1-2). 147–155. 13 indexed citations

13.

Joseph, Erin, Bruce Ganem, Julie L. Eiseman, & Donald J. Creighton. (2005). Selective Inhibition of MCF-7^piGST Breast Tumors Using Glutathione Transferase-Derived 2-Methylene-cycloalkenones. Journal of Medicinal Chemistry. 48(21). 6549–6552. 9 indexed citations

14.

Harrold, John M., Julie L. Eiseman, Erin Joseph, et al.. (2005). Control-Relevant Modeling of the Antitumor Effects of 9-Nitrocamptothecin in SCID Mice Bearing HT29 Human Colon Xenografts. Journal of Pharmacokinetics and Pharmacodynamics. 32(1). 65–83. 3 indexed citations

15.

Covey, Joseph M., Merrill J. Egorin, Julianne L. Holleran, et al.. (2005). Preclinical pharmacokinetics and metabolism of benzaldehyde dimethane sulfonate (BEN) (NSC 281612). 65. 321–322. 1 indexed citations

16.

Garimella, Τushar, D D Ross, Julie L. Eiseman, et al.. (2004). Plasma pharmacokinetics and tissue distribution of the breast cancer resistance protein (BCRP/ABCG2) inhibitor fumitremorgin C in SCID mice bearing T8 tumors. Cancer Chemotherapy and Pharmacology. 55(2). 101–109. 14 indexed citations

17.

Eiseman, Julie L., Jing Lan, Theodore Lagattuta, et al.. (2004). Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts. Cancer Chemotherapy and Pharmacology. 55(1). 21–32. 119 indexed citations

18.

Zamboni, William C., Anne Gervais, Merrill J. Egorin, et al.. (2004). Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma. Cancer Chemotherapy and Pharmacology. 53(4). 329–336. 133 indexed citations

19.

Eiseman, Julie L., Paul E. Kinahan, Jerry M. Collins, et al.. (2004). Distribution of 1-(2-Deoxy-2-fluoro-β-d-arabinofuranosyl) Uracil in Mice Bearing Colorectal Cancer Xenografts. Clinical Cancer Research. 10(19). 6669–6676. 13 indexed citations

20.

Joseph, Erin, et al.. (1990). Mesalazine: An Overview of Key Preclinical Studies. Scandinavian Journal of Gastroenterology. 25(sup172). 52–55. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact